Maxim Group Initiates Nasus Pharma Coverage With Buy Rating
Maxim Group set a $7 price target for Nasus Pharma, implying 119.4% upside from the Oct. 29 close of $3.19.
Maxim Group set a $7 price target for Nasus Pharma, implying 119.4% upside from the Oct. 29 close of $3.19.